SCHEMBL4606120

SCHEMBL4606120

CC1C2CC3CC(c4ccc(O)c(-c5ccccc5)c4)(C2)CC1(c1ccc(O)c(-c2ccccc2)c1)C3

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.37
POLB P06746 1/20 0.37
GAA P10253 1/20 0.37
GFER P55789 1/20 0.37
KMT2A Q03164 1/20 0.37
GRIN2D O15399 1/20 0.33
GRIN3B O60391 1/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2A Q12879 1/20 0.33
GRIN2B Q13224 1/20 0.33
GRIN2C Q14957 1/20 0.33
GRIN3A Q8TCU5 1/20 0.33
ALDH1A1 P00352 4/20 0.33
BACE1 P56817 2/20 0.33
ALOX5AP P20292 1/20 0.31
CYP2D6 P10635 1/20 0.31
LMNA P02545 1/20 0.30
HSD11B1 P28845 4/20 0.30
PGR P06401 1/20 0.30
MAOA P21397 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6759206 0.82 MEN1 (0.38) MEN1POLBGAAGFERKMT2A
SCHEMBL4606562 0.82 MEN1 (0.41) MEN1POLBGAAGFERKMT2A
SCHEMBL3974233 0.82 MEN1 (0.51) MEN1POLBGAAGFERKMT2A
SCHEMBL4606649 0.80 MEN1 (0.39) MEN1POLBGAAGFERKMT2A
SCHEMBL22500467 0.76 MEN1 (0.63) MEN1POLBGAAGFERKMT2A
SCHEMBL6763594 0.76 MEN1 (0.46) MEN1POLBGAAGFERKMT2A
SCHEMBL30375298 0.76 MEN1 (0.46) MEN1POLBGAAGFERKMT2A
SCHEMBL17042615 0.72 PTPN11 (0.40) MEN1POLBGAAGFERKMT2A
SCHEMBL17042487 0.70 MEN1 (0.38) MEN1POLBGAAGFERKMT2A
SCHEMBL17042864 0.70 GRIN2D (0.52) MEN1POLBGAAGFERKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1336597-B1 Hydroxyphenyl adamantanes and process for the production of the same HONSHU CHEMICAL IND (JP) 2008-07-16 EP disclosed
US-6720460-B2 FORMING HEAT RESISTANT, MECHANICAL STRENGTH POLYMER ADDITIVES; ACID CATALYZED REACTION OF ADAMANTANE DIOL OR TRIOL WITH PHENOLIC DERIVATIVE HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2004-04-13 US disclosed
US-20030187307-A1 Hydroxyphenyl adamantanes and process for the production of the same HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2003-10-02 US disclosed
EP-1336597-A1 Hydroxyphenyl adamantanes and process for the production of the same Honshu Chemical Industry Co., Ltd. (JP) 2003-08-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187307-A1 Hydroxyphenyl adamantanes and process for the production of the same CYP8B1, DHPS, P4HA1 MEN1 1025/4885POLB 727/4885GAA 1520/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.